Extracellular Matrix News 8.42 October 26, 2017 | |
| |
TOP STORYRac3 Regulates Breast Cancer Invasion and Metastasis by Controlling Adhesion and Matrix Degradation Scientists demonstrated that Rac3 GTPase is critical for integrating the adhesion of invadopodia to the ECM with their ability to degrade the ECM in breast tumor cells. [J Cell Biol] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers elucidated the function of extracellular matrix protein 1 (ECM1) on cell metastasis and glucose metabolism in gastric cancer (GC). The level of ECM1 in sera and tissues of patients with GC were positively correlated with tumor invasion and recurrence. Genetic manipulation of ECM1 expression affected cell metastasis and glucose metabolism in GC cell lines. [Oncogene] Abstract Investigators developed hybrid-spheroids of human turbinate mesenchymal stem cells (hTMSCs) by using ECM mimicking fragmented fibers for improvement of the viability and functions of hTMSCs. [Acta Biomater] Abstract Scientists demonstrated the crucial role of miR-145 in the modulation of tumor necrosis factor (TNF)-α-mediated signaling and cartilage matrix degradation. MicroRNA expression profiles of TNF-α-stimulated chondrocytes showed that miR-145 expression was rapidly downregulated by TNF-α. [Cell Death Dis] Full Article The authors report the use of decellularized Caprine liver ECM (CLECM) derived hydrogel for tissue engineering applications. CLECM was used as a substrate coating material for 2D hepatocyte culture. HepG2 cells cultured on CLECM coated surface showed higher albumin, urea, glycogen and GAGs synthesis in comparison to collagen coated surface. [J Tissue Eng Regen Med] Abstract The authors investigated whether senescent hepatocytes secreted matrix metalloproteinases and if this was regulated by nuclear factor-κB. [Life Sci] Abstract PYK2 Mediates BzATP-Induced Extracellular Matrix Proteins Synthesis Researchers investigated the effects of proline-rich tyrosine kinase 2 (PYK2) on BzATP-induced extracellular matrix protein production in osteoblasts. [Biochem Biophys Res Commun] Abstract Melanoma Topology Reveals a Stem-Like Phenotype that Promotes Angiogenesis Controlling the geometry at the interface of a population of melanoma cells reveals a role for perimeter topology in promoting a stem-like state with enhanced tumorigenicity. Scientists showed that this putative melanoma-initiating cell demonstrates significant enhancement in the secretion of proangiogenic molecules. [Sci Adv] Full Article Template Curvature Influences Cell Alignment to Create Improved Human Corneal Tissue Equivalents To accurately create corneal stromal equivalents with native-like structure and composition, a new biofunctionalized, curved template was developed that allows the precise orientation of cells and of their extracellular matrix. [Adv Biosyst] Full Article | |
| |
REVIEWSTGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases The authors summarize the role of the transforming growth factor β (TGF-β) signaling pathway and endothelial-mesenchymal transition in the development of fibrotic diseases and discuss their therapeutic potential. [Int J Mol Sci] Full Article Visit our reviews page to see a complete list of reviews in the extracellular matrix research field. | |
| |
SCIENCE NEWSInSphero to Present Novel 3D Human Liver Fibrosis Model InSphero AG will present data characterizing and demonstrating the utility of its new 3D InSightâ„¢ Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs. [Press release from InSphero AG discussing research presented at the American Association for the Study of Liver Disease (AASLD) Conference, Washington] Press Release | |
| |
INDUSTRY NEWSAntibe Therapeutics Announces Key US Distribution Partnership for Its Subsidiary, Citagenix Antibe Therapeutics Inc. announced that its subsidiary, Citagenix Inc, has been selected by Darby Dental Supply, LLC to be its supplier of premium bone grafting and tissue regeneration products. [Antibe Therapeutics Inc.] Press Release Astellas Pharma Inc. and Universal Cells, Inc. announced that Astellas Institute for Regenerative Medicine and Universal Cells have entered into an exclusive worldwide license agreement to research, develop and commercialize a novel cell therapy for an undisclosed indication. [Astellas Pharma Inc.] Press Release | |
| |
POLICY NEWSKey Legislator Tells Trump Officials to Back Off on Proposed Overhead Spending Cap for NIH An influential legislator wants President Donald Trump’s administration and fellow Republicans to drop the notion of capping overhead costs on grants funded by the National Institutes of Health (NIH). [ScienceInsider] Editorial China Announces Plans to Fast-Track Drug Approval China is overhauling its drug-approval system to let companies bring their treatments to market quicker and more easily. The Communist Party of China and the State Council, two of the country’s most authoritative bodies, announced plans to reduce the backlog of medicines awaiting approval by the China Food and Drug Administration (CFDA). Policies will also be introduced to boost the productivity of Chinese drugmakers and spur innovation in health care. [Nature News] Editorial United States Should Dramatically Retool Animal Research Rules, Groups Say The Association of American Medical Colleges and three allied groups are pushing for sweeping changes to animal research rules. In a report, the groups call for moving all oversight to a single, unnamed agency, conducting less frequent lab inspections, and giving researchers greater say in crafting new rules. [ScienceInsider] Editorial
| |
EVENTSNEW 2018 Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postgraduate Position – Biomaterials (University of East Anglia) Assistant Professor – Stem Cell And Regenerative Biology (Columbia University) Postdoctoral Fellow – Inflammatory Bowel Disease (Emory University) Postdoctoral Position – Bioengineering and Regenerative Medicine (Maastricht University) Postdoctoral Positions – Neuroscience (Harvard Medical School) Assistant or Associate Professor – Biomedical Engineering (University of British Columbia) Postdoctoral Position – Wound Healing (University of Connecticut Health Center) Postdoctoral Research Fellowship – Kidney Disease (Vanderbilt University Medical Center) Postdoctoral Researchers – Cancer Metastasis and Drug Resistance (Tufts University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Extracellular Matrix News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|